According to CB INSIGHTS, our portfolio company Geen is among the most disruptive 60+ SyntheticBiology Startups.
CB INSIGHTS mapped 67 Synthetic Biology startups under 9 categories, where Geen was selected among the most disruptive startups under Organism engineering & automation platforms.
Geen is building an operating system to make cells programmable. GeenOS introduces a new Universal and Computable genetic coding language upon integration to any host cell.